Prioritisation and Intelligent Testing of Pharmaceuticals
May 8th, 2015, Barcelona (Spain)

Universitat Pompeu Fabra (Auditorium, Campus Poblenou)
Carrer Roc Boronat, 138
08018 Barcelona

Intelligence-led Assessment of Pharmaceuticals in the Environment (iPiE) is a 10.2 M Euro IMI project1, involving leading researchers from academia and the pharmaceutical industry, that aims to develop a framework (using information from toxicological studies, pharmacological mode of action and predictive models) for identifying the potential risks of human pharmaceuticals to the natural environment (considering both aquatic and terrestrial systems, including top predators). In the future this framework should be used to better target environmental testing requirements at an early stage in drug development programmes and for prioritising legacy pharmaceuticals for experimental testing and monitoring.

As a first step in the project, members of the iPiE consortium are developing draft frameworks for prioritisation and intelligent testing of pharmaceuticals. These frameworks will help to steer subsequent development work and experimental testing in the project. To ensure that the frameworks are optimum, based on the best science and that they address needs of different stakeholders, we would like to present and discuss the draft frameworks with a broader range of stakeholders.

To achieve this aim, we will be running a one-day workshop the day after the SETAC Europe conference in Barcelona. During the day the overall iPiE project will be presented along with our proposals for approaches for prioritisation and intelligent testing. Workshop attendees will then work in break out groups to discuss the proposed frameworks and recommend improvements. The agenda for the day is provided below.